Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
UMKC-powered tech could help visually-impaired Kansas Citians see via artificial intelligence
Gharib Gharibi is driven to succeed by a desire to pay it forward, he said, riding a high from his startup’s first-place, $20,000 win at UMKC’s Regnier Institute Venture Creation Challenge. “They helped us transform our technology from the computer lab to the real world,” Gharibi, founder of DeepLens and a UMKC PhD student, said…
iWerx Gladstone opens, expanding Northland coworking community (Photos)
Northland startups and business owners need more collaborative workplaces to call their own, Bob Martin said less than a year ago. This week, iWerx Gladstone turns that vision into reality. “More than just a place to work, iWerx Gladstone is a business development center committed to making connections and stimulating personal and professional growth,” said…
Look inside (and out): Corrigan Station expansion offers startups skyline views from within Crossroads
Decades have passed since the last new office building opened in the Crossroads Arts District, said Edna Martinson. In a matter of weeks, startups and small businesses can “create their own vibe” when the 22,910-square-foot Corrigan Station expansion project — led by Copaken-Brooks — unlocks its doors and opens them to Kansas City innovators, added Martinson,…
$18M buyout of TomboyX shares shows investing in women pays off, says Women’s Capital Connection
Women are winning in Kansas City, said Kelly Sievers as 24 members of Women’s Capital Connection receive their return from an $18-million buyout of their shares in a Seattle woman’s startup. “They’re getting a great infusion of capital to grow even more and we also still have money in the company because we invested a…